MedTrace Logo

Effects of Bitter Melon on Cardiometabolic Health

NCT05540405 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-05-31

No results posted yet for this study

Summary

The objectives of this study are to assess the effects of a bitter melon product at two doses, compared to control, on indicators of cardiometabolic health among men and women with prediabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Low-dose bitter melon

Subject will receive 1 Insumate bitter melon capsule/d (300 mg) and 1 placebo capsule/d (300 mg)

DIETARY_SUPPLEMENT

High-dose bitter melon

Subject will receive 2 Insumate bitter melon capsules/d (300 mg each)

DIETARY_SUPPLEMENT

Placebo

Subject will receive 2 placebo capsules/d (300 mg each)

Sponsors & Collaborators

  • Greenyn Biotechnology

    collaborator UNKNOWN

  • Midwest Center for Metabolic and Cardiovascular Research

    lead OTHER

Principal Investigators

  • Kevin C Maki, PhD · MB Clinical Research & Consulting

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-24
Primary Completion
2023-05-24
Completion
2023-05-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540405 on ClinicalTrials.gov